首页> 外文期刊>Phytochemical Analysis >Quantitative analysis of safranal in saffron extract and nanoparticle formulation by a validated high-performance thin-layer chromatographic method
【24h】

Quantitative analysis of safranal in saffron extract and nanoparticle formulation by a validated high-performance thin-layer chromatographic method

机译:验证的高效薄层色谱法定量分析藏红花提取物和纳米颗粒配方中的茄红素

获取原文
获取原文并翻译 | 示例
       

摘要

Introduction - Safranal is an effective anticonvulsant shown to act as an agonist at GABAA receptors. Nose to brain delivery via nanoparticle formulation might improve its brain delivery. A selective and sensitive analytical method is required for evaluation of safranal-based novel drug delivery systems.Objective - To develop and validate a high-performance thin-layer chromatographic (HPTLC) method for the quantitative analysis of safranal as bulk, in saffron extract and in developed safranal-loaded nanoparticle formulation.Methodology - Chromatographic separation was achieved on silica gel pre-coated TLC aluminium plates 60F-254, using n-hexane:ethyl acetate (9 : 1, v/v) as the mobile phase. Quantitative analysis was carried out by densitometry at a wavelength of 310 nm. The method was validated and applied to detect related impurities, to analyse safranal in saffron extract and to evaluate safranal-loaded nanoparticles.Results - Compact spots of safranal were observed at Rf value 0.51 pl 0.02. The method was linear (r = 0.9991) between 0.5 and 5.0 og/spot. The intra- and inter-day precisions were 1.08-2.17 and 1. 86-3.47%, respectively. The limit of detection was 50 ng/spot and the limit of quantification was 150 ng/spot. The method proved to be accurate (recovery 97.4-102.0%) and was selective for safranal. Evaluation of safranal-loaded nanoparticle formulation demonstrated drug loading of 23.0%, encapsulation efficiency of 42.0% and sustained drug release following biphasic pattern.Conclusion - The present method is useful for the quantitative and qualitative analysis of safranal and safranal-loaded nanoparticle formulation. It provides significant advantages in terms of greater specificity and rapid analysis
机译:简介-Safranal是一种有效的抗惊厥药,在GABAA受体上起激动剂的作用。通过纳米颗粒制剂将鼻子导入脑部可能会改善其脑部递送。评价基于To的新型药物递送系统需要一种选择性和灵敏的分析方法。目的-建立并验证一种高效薄层色谱法(HPTLC),用于定量分析藏红花提取物中的fra的散装含量。方法-在硅胶预涂的TLC铝板60F-254上使用正己烷:乙酸乙酯(9:1,v / v)作为流动相进行色谱分离。通过光密度法在310nm的波长下进行定量分析。验证了该方法的有效性,可用于相关杂质的检测,藏红花提取物中sa的分析和荷载纳米颗粒的评价。结果-fra的致密斑点在Rf值为0.51 pl 0.02。该方法是线性的(r = 0.9991)在0.5和5.0 og /点之间。日内和日间精度分别为1.08-2.17和1。86-3.47%。检测限为50 ng / spot,定量限为150 ng / spot。该方法被证明是准确的(回收率97.4-102.0%),对sa虫具有选择性。评估fra载纳米颗粒制剂的药物载量为23.0%,包封效率为42.0%,并且在两相模式后持续释放。结论-本方法可用于对sa载纳米颗粒制剂进行定量和定性分析。就更高的特异性和快速分析而言,它具有明显的优势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号